Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma.
Gortzak E, Azzarelli A, Buesa J, Bramwell VH, van Coevorden F, van Geel AN, Ezzat A, Santoro A, Oosterhuis JW, van Glabbeke M, Kirkpatrick A, Verweij J; E.O.R.T.C. Soft Tissue Bone Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group/Canadian Sarcoma Group. Gortzak E, et al. Among authors: buesa j. Eur J Cancer. 2001 Jun;37(9):1096-103. doi: 10.1016/s0959-8049(01)00083-1. Eur J Cancer. 2001. PMID: 11378339 Clinical Trial.
Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
Pinedo HM, Bramwell VH, Mouridsen HT, Somers R, Vendrik CP, Santoro A, Buesa J, Wagener T, van Oosterom AT, van Unnik JA, et al. Pinedo HM, et al. Among authors: buesa j. Cancer. 1984 May 1;53(9):1825-32. doi: 10.1002/1097-0142(19840501)53:9<1825::aid-cncr2820530904>3.0.co;2-z. Cancer. 1984. PMID: 6367947 Clinical Trial.
Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Bramwell V, Rouesse J, Steward W, Santoro A, Schraffordt-Koops H, Buesa J, Ruka W, Priario J, Wagener T, Burgers M, et al. Bramwell V, et al. Among authors: buesa j. J Clin Oncol. 1994 Jun;12(6):1137-49. doi: 10.1200/JCO.1994.12.6.1137. J Clin Oncol. 1994. PMID: 8201375 Clinical Trial.
High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group.
Nielsen OS, Dombernowsky P, Mouridsen H, Crowther D, Verweij J, Buesa J, Steward W, Daugaard S, van Glabbeke M, Kirkpatrick A, Tursz T. Nielsen OS, et al. Among authors: buesa j. Br J Cancer. 1998 Dec;78(12):1634-9. doi: 10.1038/bjc.1998.735. Br J Cancer. 1998. PMID: 9862576 Free PMC article. Clinical Trial.
Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
Van Glabbeke M, van Oosterom AT, Oosterhuis JW, Mouridsen H, Crowther D, Somers R, Verweij J, Santoro A, Buesa J, Tursz T. Van Glabbeke M, et al. Among authors: buesa j. J Clin Oncol. 1999 Jan;17(1):150-7. doi: 10.1200/JCO.1999.17.1.150. J Clin Oncol. 1999. PMID: 10458228
Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: a study of the european organization for research and treatment of cancer soft tissue and bone sarcoma group.
Verweij J, Lee SM, Ruka W, Buesa J, Coleman R, van Hoessel R, Seynaeve C, di Paola ED, van Glabbeke M, Tonelli D, Judson IR. Verweij J, et al. Among authors: buesa j. J Clin Oncol. 2000 May;18(10):2081-6. doi: 10.1200/JCO.2000.18.10.2081. J Clin Oncol. 2000. PMID: 10811673 Clinical Trial.
Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma Group.
Blackledge G, Steward WP, Verweij J, Mouridsen H, Bramwell V, Schütte J, van Oosterom A, Dombernowsky P, Buesa J, Van Glabekke M, et al. Blackledge G, et al. Among authors: buesa j. Semin Oncol. 1992 Feb;19(1 Suppl 1):14-8. Semin Oncol. 1992. PMID: 1411615 Review.
182 results